Laddar...
Current Chemotherapy and Potential New Targets in Uterine Leiomyosarcoma
A variety of chemotherapeutic agents have been used for treating recurrent or advanced stage uterine leiomyosarcoma (ULMS). The response rates of these current agents are disappointing, with partial response rates varying from 0% to 33%, and complete response rates varying from 0% to 8%. Recent stud...
Sparad:
| I publikationen: | J Clin Med Res |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Elmer Press
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4737027/ https://ncbi.nlm.nih.gov/pubmed/26858789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2419w |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|